Vanda Pharmaceuticals
VNDA
#7679
Rank
C$0.50 B
Marketcap
C$8.58
Share price
-5.61%
Change (1 day)
30.81%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2024 the company made an earning of -C$55.99 Million a decrease over its 2023 earnings that were of -C$19.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion203.16%
2024 -C$55.99 Million191.43%
2023 -C$19.22 Million-320.45%
2022 C$8.71 M-84.99%
2021 C$58.06 M54.8%
2020 C$37.5 M19.42%
2019 C$31.4 M4.93%
2018 C$29.93 M-228.6%
2017 -C$23.28 Million-8.98%
2016 -C$25.58 Million-53.79%
2015 -C$55.34 Million-30.18%
2014 -C$79.26 Million173.08%
2013 -C$29.03 Million-25.33%
2012 -C$38.87 Million163.61%
2011 -C$14.75 Million-221.15%
2010 C$12.16 M-124.53%
2009 -C$49.62 Million-29.44%
2008 -C$70.32 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$90.49 Million170.55%
2005 -C$33.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.60 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$30.98 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.60 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.06 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.32 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$3.87 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.79 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA